The use of hydroxychloroquine as a systemic treatment in erosive lichen planus of the vulva and vagina.

The use of hydroxychloroquine as a systemic treatment in erosive lichen planus of the vulva and vagina.
Br J Dermatol. 2021 Feb 06;:
Authors: Vermeer HAB, Rashid H, Esajas MD, Oldhoff JM, Horváth B
Abstract
Erosive lichen planus affecting the vulva and vagina (ELPV) is a rare inflammatory skin disease, presenting with painful erosions and severe scarring.1 The disease course is persistent and often refractory to treatment: up to 45% patients do not experience remission with topical treatments, while evidence for systemic treatments remains scarce.2 Hydroxychloroquine (HCQ) is frequently used in daily practice as a first choice systemic therapy.3 However, little evidence is available on HCQ for ELPV.2 The aim of this study was to analyse the effectiveness and safety of HCQ in ELPV.
PMID: 33548058 [PubMed - as supplied by publisher]

Source: The British Journal of Dermatology - February 6, 2021 Category: Dermatology Authors: Vermeer HAB, Rashid H, Esajas MD, Oldhoff JM, Horváth B Tags: Br J Dermatol Source Type: research